色素沉澱疾病治療市場 - 按治療類型、疾病類型 - 全球預測 2024 - 2032

Pigmentation Disorder Treatment Market - By Treatment Type, Type of Disorder - Global Forecast 2024 - 2032

出版日期: 2024年03月15日 | 出版商:

Global Market Insights Inc. | 英文 125 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於全球人口對色素沉著疾病及其對皮膚健康影響的認知不斷提高，色素沉著疾病治療市場規模在 2024 年至 2032 年間可能會實現 5.8% 的複合年成長率。隨著人們越來越注重自己的外表並尋求解決皮膚問題，對先進色素沉著治療的需求不斷增加。此外，皮膚病學研究和醫療技術的進步促進了創新治療方案的發展。

隨著壽命的延長和暴露於紫外線輻射等環境因素的影響，黃褐斑、色素沉著過度和白斑症等色素沉著疾病的盛行率進一步增加。根據全球白斑症基金會的數據，白斑影響全世界 7,000 萬人，不存在種族、民族或性別的障礙。大約20-35%的白斑症患者是兒童。因此，對安全、有效和微創治療方案來管理這些疾病的需求不斷成長。社群媒體和美容標準的影響力日益增強，激發了人們對完美肌膚的渴望，進一步推動了對色素沉著療程的需求

整個產業分為治療類型、疾病類型和地區。

根據治療類型，預計到 2032 年，手術領域的色素沉著障礙治療市場價值複合年成長率將達到 5.5%。這是由於對旨在有效解決色素沉著障礙的先進皮膚科手術的需求不斷增加。雷射治療、化學換膚、微晶煥膚和強烈脈衝光 (IPL) 治療等手術可為各種色素沉著問題提供有針對性的精確解決方案。此外，程序技術的進步正在改善治療結果，同時最大限度地減少停機時間和副作用，從而提高患者滿意度。

就疾病類型而言，由於色素沉著過度的廣泛流行和消費者意識的提高，預計從 2024 年到 2032 年，色素沉著過度治療市場的複合年成長率將達到 5.7%。由於陽光照射、荷爾蒙波動和老化等因素會導致色素沉著過度，因此對有效治療方案來解決這一常見皮膚問題的需求不斷成長。專門針對色素沉著過度客製化的治療方式的進步，以及專業護膚服務的不斷增加，也有利於該細分市場的成長。

由於人口多樣化和氣候條件變化，2024年至2032年間，亞太地區色素沉著障礙治療產業規模將以複合年成長率6.4%的速度快速擴張。發病率的增加，加上可支配收入的增加和人們對皮膚護理意識的不斷增強，正在推動對有效治療方案的需求。先進皮膚科手術和護膚技術的不斷普及以及藥妝品的日益普及將進一步推動亞太地區的市場成長。

產業生態系統分析
產業影響力
- 成長動力
  - 擴大採用先進的皮膚護理程序
  - 色素沉澱疾病的盛行率不斷增加
  - 皮膚科治療支出不斷增加
  - 年輕人對皮膚健康的認知不斷提高
- 產業陷阱與挑戰
  - 整容手術費用高
  - 缺乏報銷政策
成長潛力分析
監管環境
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
競爭定位矩陣
戰略儀錶板

第 5 章：市場估計與預測：按治療類型，2018 - 2032 年

主要趨勢
藥品
- 按類型
  - 皮質類固醇
  - 黑色素細胞刺激激素
  - 其他藥品
- 依給藥途徑
  - 口服
  - 專題
  - 其他給藥途徑
- 按配銷通路
  - 醫院藥房
  - 零售藥局
  - 網路藥局
程式
- 按類型
  - 雷射治療
  - 光療
  - 磨皮術
  - 其他手續
- 按最終用戶
  - 醫院
  - 皮膚科診所
  - 美容中心
  - 其他最終用戶

第 6 章：市場估計與預測：按疾病類型，2018 年 - 2032 年

主要趨勢
色素沉澱不足
- 白斑
- 白化病
- 其他色素沉著不足
色素沉著過度
- 黃褐斑
- 雀斑痣
- 發炎後色素沉著（PIH）
- 其他色素沉著過度

第 7 章：市場估計與預測：按地區分類，2018 年 - 2032 年

主要動向：按地區
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 中東和非洲其他地區

第 8 章：公司簡介

AbbVie Inc.
Candela Corporation
Cipher Pharmaceuticals Inc.
Galderma
GSK plc
Incyte
L'Oréal Paris
Novartis AG
Pfizer Inc.
Pierre Fabre group
Shiseido Company Limited

簡介目錄

Product Code: 8528

Pigmentation disorder treatment market size is likely to register 5.8% CAGR between 2024 to 2032, driven by the increasing awareness among the global population about pigmentation disorders and their impact on skin health. As individuals are becoming more conscious about their appearance and seeking to address skin concerns, the demand for advanced pigmentation treatments is on the rise. Additionally, advancements in dermatological research and medical technology have led to the development of innovative treatment options.

With increasing longevity and exposure to environmental factors like UV radiation, the prevalence of pigmentation disorders, such as melasma, hyperpigmentation, and vitiligo is further growing. As per Global Vitiligo Foundation, vitiligo affects 70 million people worldwide, with no barriers based on race, ethnicity, or gender. Around 20-35% of vitiligo patients are children. As a result, there is a growing demand for safe, effective, and minimally invasive treatment options to manage these conditions. The growing influence of social media and beauty standards has fueled the desire for flawless skin, further driving the demand for pigmentation treatments

The overall industry is segmented the into treatment type, type of disorder, and region.

Based on treatment type, the pigmentation disorder treatment market value from the procedures segment is anticipated to witness 5.5% CAGR through 2032. This is due to the increasing demand for advanced dermatological procedures aimed at addressing pigmentation disorders effectively. Procedures, such as laser therapy, chemical peels, microdermabrasion, and intense pulsed light (IPL) treatments offer targeted and precise solutions for various pigmentation concerns. Moreover, advancements in procedural techniques and technologies are improving treatment outcomes while minimizing downtime and side effects for enhancing patient satisfaction.

In terms of type of disorder, the hyperpigmentation segment in the pigmentation disorder treatment market is estimated to record 5.7% CAGR from 2024 to 2032, due to its widespread prevalence and increasing awareness among consumers. With factors, such as sun exposure, hormonal fluctuations, and aging contributing to the development of hyperpigmentation, there is a growing demand for effective treatment options to address this common skin concern. Advancements in treatment modalities tailored specifically for hyperpigmentation, along with the growing availability of professional skincare services are also favoring the segment growth.

Asia Pacific pigmentation disorder treatment industry size will witness rapid expansion at 6.4% CAGR between 2024-2032, attributed to the diverse population and varying climate conditions. This increased incidence, coupled with rising disposable incomes and growing awareness about skincare is fueling the demand for effective treatment options. The expanding availability of advanced dermatological procedures and skincare technologies along with the rising adoption of cosmeceuticals will further propel the market growth in the Asia Pacific.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing adoption of advanced skin care procedures
  - 3.2.1.2 Increasing prevalence of pigmentation disorders
  - 3.2.1.3 Growing expenditure on dermatological treatments
  - 3.2.1.4 Rising awareness regarding skin health among younger population
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of cosmetic procedures
  - 3.2.2.2 Lack of reimbursement policies
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
- 3.5.1 Supplier power
- 3.5.2 Buyer power
- 3.5.3 Threat of new entrants
- 3.5.4 Threat of substitutes
- 3.5.5 Industry rivalry
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Treatment Type, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Drugs
- 5.2.1 By type
  - 5.2.1.1 Corticosteroids
  - 5.2.1.2 Melanocyte-stimulating hormone
  - 5.2.1.3 Other drugs
- 5.2.2 By route of administration
  - 5.2.2.1 Oral
  - 5.2.2.2 Topical
  - 5.2.2.3 Other routes of administrations
- 5.2.3 By distribution channel
  - 5.2.3.1 Hospital pharmacies
  - 5.2.3.2 Retail pharmacies
  - 5.2.3.3 Online pharmacies
5.3 Procedures
- 5.3.1 By type
  - 5.3.1.1 Laser treatment
  - 5.3.1.2 Phototherapy
  - 5.3.1.3 Dermabrasion
  - 5.3.1.4 Other procedures
- 5.3.2 By end-user
  - 5.3.2.1 Hospitals
  - 5.3.2.2 Dermatology clinics
  - 5.3.2.3 Aesthetic centers
  - 5.3.2.4 Other end-users

Chapter 6 Market Estimates and Forecast, By Type of Disorder, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Hypopigmentation
- 6.2.1 Vitiligo
- 6.2.2 Albinism
- 6.2.3 Other hypopigmentations
6.3 Hyperpigmentation
- 6.3.1 Melasma
- 6.3.2 Lentigines
- 6.3.3 Post-inflammatory hyperpigmentation (PIH)
- 6.3.4 Other hyperpigmentations

Chapter 7 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

7.1 Key trends, by region
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Rest of Europe
7.4 Asia Pacific
- 7.4.1 Japan
- 7.4.2 China
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 Rest of Middle East and Africa